# Mark Davies

> UK bioinformatician

**Wikidata**: [Q43370916](https://www.wikidata.org/wiki/Q43370916)  
**Source**: https://4ort.xyz/entity/mark-davies

## Summary
Mark Davies is a UK bioinformatician and computer scientist based in London, currently employed at the European Bioinformatics Institute (EMBL-EBI). He specializes in biomedical informatics, molecular genetics, biotechnology, and druggability research, particularly in the context of chemogenomics and the ChEMBL database.

## Biography
- Born: [date and place not specified]
- Nationality: United Kingdom
- Education: [degrees and institutions not specified]
- Known for: Contributions to biomedical informatics, particularly in druggability and chemogenomics research.
- Employer(s): European Bioinformatics Institute (EMBL-EBI)
- Field(s): Biomedical informatics, molecular genetics, biotechnology, druggability, chemogenomics, ChEMBL

## Contributions
Mark Davies has made significant contributions to the field of biomedical informatics, focusing on druggability and chemogenomics. His work is closely tied to the ChEMBL database, a key resource in the field. As a bioinformatician, he has likely contributed to the development and maintenance of bioinformatics tools and databases that support drug discovery and molecular genetics research. His research may involve analyzing large datasets to identify potential drug targets or understanding the genetic basis of diseases. His work at EMBL-EBI, a leading institution in bioinformatics, suggests he has played a role in advancing the field through computational approaches.

## FAQs
### Q: What is Mark Davies known for?
A: Mark Davies is known for his work in biomedical informatics, particularly in druggability and chemogenomics research, and his contributions to the ChEMBL database.

### Q: Where does Mark Davies work?
A: Mark Davies is currently employed at the European Bioinformatics Institute (EMBL-EBI) in London.

### Q: What fields does Mark Davies specialize in?
A: Mark Davies specializes in biomedical informatics, molecular genetics, biotechnology, druggability, and chemogenomics.

### Q: Has Mark Davies published any notable works?
A: Specific publications by Mark Davies are not mentioned in the provided source material.

### Q: What is the ChEMBL database, and how is Mark Davies involved?
A: The ChEMBL database is a resource for drug discovery, and Mark Davies has contributed to its development and research in druggability and chemogenomics.

## Why They Matter
Mark Davies' work in biomedical informatics has likely contributed to advancements in drug discovery and molecular genetics. His research in druggability and chemogenomics has the potential to accelerate the development of new treatments by identifying potential drug targets. As part of the EMBL-EBI, he has access to cutting-edge bioinformatics tools and databases, which he may have used to support his research. His contributions to the ChEMBL database have likely enhanced its utility for researchers in the field, making it a more comprehensive resource for drug discovery. Without his work, the field of biomedical informatics may have lacked certain computational approaches or insights into druggability and chemogenomics.

## Notable For
- Contributions to the ChEMBL database, a key resource in drug discovery.
- Specialization in druggability and chemogenomics research.
- Employment at the European Bioinformatics Institute (EMBL-EBI), a leading institution in bioinformatics.
- Focus on biomedical informatics, molecular genetics, and biotechnology.

## Body
### Professional Background
Mark Davies is a bioinformatician and computer scientist based in London. He is currently employed at the European Bioinformatics Institute (EMBL-EBI), where he works in the field of biomedical informatics. His primary focus areas include molecular genetics, biotechnology, druggability, and chemogenomics.

### Research and Contributions
Mark Davies' research is centered on druggability and chemogenomics, with a particular emphasis on the ChEMBL database. The ChEMBL database is a resource for drug discovery, and Mark Davies has likely contributed to its development and maintenance. His work in this area may involve analyzing large datasets to identify potential drug targets or understanding the genetic basis of diseases.

### Field of Work
Mark Davies specializes in biomedical informatics, a field that applies computer science to biological and medical data. His work in molecular genetics and biotechnology suggests he is involved in understanding the genetic basis of diseases and developing new treatments. His focus on druggability and chemogenomics indicates he is interested in identifying potential drug targets and understanding the genetic basis of diseases.

### Citations and References
Mark Davies' work is referenced in a speaker profile on the EMEDEVENTS website, where he is described as a bioinformatician and computer scientist. His contributions to the ChEMBL database and his research in druggability and chemogenomics are also mentioned in this reference. Additionally, his Semantic Scholar and ResearchGate profiles provide further insight into his academic contributions.

## References

1. [Source](https://www.emedevents.com/speaker-profile/mark-davies-2)